Estabraghnia Babaki Hamideh, Jarineshin Hashem, Saljoughi Fateme, Hassaniazad Mehdi, Rafati Shideh, Sohrabipour Shahla
Anesthesiology, Critical Care and Pain Management Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Tanaffos. 2022 Apr;21(4):455-465.
The clinical characteristics of COVID-19 are diverse from a simple common cold symptom to acute respiratory distress syndrome (ARDS). In the present study, we attempted to identify the associated factors in surviving COVID-19 intensive care unit (ICU) patients based on their clinical characteristics.
This retrospective study was performed on 114 laboratory-confirmed COVID-19 patients admitted to the intensive care units of Hormozgan University of Medical Sciences, Iran. Demographic, medical, clinical manifestations at admission time, and outcome data were obtained from the patient's medical records.
Of 114 participants included in this study, 64.9% were men. Their mean age was approximately 54 years old, 69.3% of them died and 30.7% of them were discharged. The mortality rate was 2.96 times higher in people who had ARDS compared to their counterparts, 1.37 times higher in people under non-invasive ventilation, and 3.56 times higher in people under invasive mechanical ventilation.Three common underlying diseases among them were hypertension in 34.2%, diabetes in 23.7%, and cardiovascular diseases in 17.5% of them. Alive and dead patients significantly differed only in the following laboratory tests: D-dimer, urea, troponin, Procalcitonin, and ferritin.
The mortality rate among COVID-19 patients admitted to ICU is generally high. Dyspnea, as the initial presentation and comorbidity, especially hypertension, diabetes, and cardiovascular diseases, may be associated with a higher risk of developing severe disease and consequent mortality. Therefore, D-dimer, urea, troponin, Procalcitonin, and ferritin at the time of hospital admission could predict the severity of the disease and its probable mortality.
新型冠状病毒肺炎(COVID-19)的临床特征多种多样,从简单的普通感冒症状到急性呼吸窘迫综合征(ARDS)。在本研究中,我们试图根据COVID-19重症监护病房(ICU)患者的临床特征确定其生存的相关因素。
本回顾性研究对伊朗霍尔木兹甘医科大学重症监护病房收治的114例实验室确诊的COVID-19患者进行。人口统计学、医学、入院时的临床表现及结局数据均从患者病历中获取。
本研究纳入的114名参与者中,64.9%为男性。他们的平均年龄约为54岁,其中69.3%死亡,30.7%出院。与无ARDS的患者相比,发生ARDS的患者死亡率高2.96倍;无创通气患者死亡率高1.37倍;有创机械通气患者死亡率高3.56倍。其中三种常见基础疾病分别为高血压(34.2%)、糖尿病(23.7%)和心血管疾病(17.5%)。存活和死亡患者仅在以下实验室检查结果上存在显著差异:D-二聚体、尿素、肌钙蛋白、降钙素原和铁蛋白。
入住ICU的COVID-19患者死亡率普遍较高。呼吸困难作为初始表现及合并症,尤其是高血压、糖尿病和心血管疾病,可能与发生重症疾病及随之而来的死亡风险较高有关。因此,入院时的D-二聚体、尿素、肌钙蛋白、降钙素原和铁蛋白可预测疾病的严重程度及其可能的死亡率。